WT
ANIK icon

Whittier Trust’s Anika Therapeutics ANIK Stock Holding History

Whittier Trust’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-105
Closed -$5K – 1253
2017
Q1 		$5K Buy
+105
New +$5.01K ﹤0.01% 1131
2015
Q3 		– Sell
-450
Closed -$15K – 1167
2015
Q2 		$15K Buy
+450
New +$16.1K ﹤0.01% 954

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Whittier Trust's ANIK Position: Q2 2017 in Review

Whittier Trust sold out of Anika Therapeutics (ANIK) in Q2 2017, closing a stake of 105 shares — an estimated $5K sold.

Whittier Trust first reported a position in ANIK in Q2 2015 and held it in 2 quarters. The position peaked at $15K in Q2 2015. 159 funds tracked by Wall St. Rank hold ANIK as of Q2 2017.

  • Whittier Trust reported no remaining Anika Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Whittier Trust sold 105 Anika Therapeutics shares in Q2 2017, an estimated $5K.
  • Whittier Trust first reported a position in Anika Therapeutics in Q2 2015 and held it in 2 quarters.
  • Whittier Trust's Anika Therapeutics position peaked at $15K in Q2 2015.
  • 159 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2017.

Based on Whittier Trust's 13F filing for Q2 2017, filed 20 Jul 2017.